CA Patent

CA2873315A1 — D-amino acid compounds for liver disease

Assigned to Idenix Pharmaceuticals LLC · Expires 2013-11-28 · 12y expired

What this patent protects

Provided herein are compounds comprising a D-amino acid, compositions and methods for the treatment of liver disease and conditions, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered eit…

USPTO Abstract

Provided herein are compounds comprising a D-amino acid, compositions and methods for the treatment of liver disease and conditions, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.

Drugs covered by this patent

Patent Metadata

Patent number
CA2873315A1
Jurisdiction
CA
Classification
—
Expires
2013-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Idenix Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.